NB
Nayantara Bali
About Nayantara Bali
Data last updated:
Nayantara Bali is a Director at Torrent Pharmaceuticals Ltd (since 2019) and Director at Marico Limited (since 2022). The companies operate in Pharma and FMCG. The 2 current companies with reported revenue have a combined latest revenue of ₹27,701 Cr; the largest is Torrent Pharmaceuticals Ltd at ₹13,886 Cr (FY 2026). Earlier, Nayantara Bali was a Director at Gillette India Limited (2011–2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Torrent Pharmaceuticals Ltd L24230GJ1972PLC002126 | Director | 07 Mar 2019 | 1972 | ₹13,886 Cr (FY 2026) | Active |
 Marico Limited L15140MH1988PLC049208 | Director | 07 Apr 2022 | 1988 | ₹13,815 Cr (FY 2026) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Gillette India Limited L28931MH1984PLC267130 | Director | 26 Aug 2011 | 1984 | ₹2,263 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nayantara Bali
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nayantara Bali
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nayantara Bali
Nayantara Bali currently holds 2 directorships: Torrent Pharmaceuticals Ltd (Director, since 07 Mar 2019, revenue ₹13,886 Cr (FY 2026)); Marico Limited (Director, since 07 Apr 2022, revenue ₹13,815 Cr (FY 2026)).
Nayantara Bali was first appointed on 26 Aug 2011 as Director at Gillette India Limited. The most recent appointment on record is 07 Apr 2022 at Marico Limited.
The 2 current companies of Nayantara Bali that report revenue have a combined latest revenue of ₹27,701 Cr: Torrent Pharmaceuticals Ltd ₹13,886 Cr (FY 2026); Marico Limited ₹13,815 Cr (FY 2026).
Nayantara Bali held 1 earlier board appointment: Gillette India Limited (Director, 26 Aug 2011 to 13 Mar 2013).
The current boards of Nayantara Bali's companies include Aman Samir Mehta (Torrent Pharmaceuticals Ltd), Chintan Maheshkumar Trivedi (Torrent Pharmaceuticals Ltd), Jinal Sudhirbhai Mehta (Torrent Pharmaceuticals Ltd), Manish Mahendra Choksi (Torrent Pharmaceuticals Ltd), Nikhil Khattau Nirvan (Torrent Pharmaceuticals Ltd), Samir Uttamlal Mehta (Torrent Pharmaceuticals Ltd), among others.